Page 5 - Jeffreym Jonas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jeffreym jonas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jeffreym Jonas Today - Breaking & Trending Today

FY2026 Earnings Estimate for Sage Therapeutics, Inc. (NASDAQ:SAGE) Issued By HC Wainwright

Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Rating) – Equities researchers at HC Wainwright lowered their FY2026 earnings estimates for shares of Sage Therapeutics in a report issued on Wednesday, May 3rd. HC Wainwright analyst D. Tsao now anticipates that the biopharmaceutical company will post earnings per share of $10.60 for the year, down from their […] ....

United Kingdom General , United Kingdom , Jeffreym Jonas , Steven Marc Paul , Needham Company , Blackrock Inc , Fisher Asset Management , Norges Bank , Sage Therapeutics Inc , Goldman Sachs Group Inc , Therapeutics Inc , Royal Bank , Sage Therapeutics , Get Rating , Sage Therapeutic , Sachs Group , Street Corp , Director Jeffrey , Douglas Covey , Sage Therapeutics Daily , Nasdaq Sage , Earnings Estimates , Hc Wainwright ,

Sage Therapeutics (NASDAQ:SAGE) Releases Earnings Results, Beats Estimates By $0.04 EPS

Sage Therapeutics (NASDAQ:SAGE – Get Rating) posted its earnings results on Tuesday. The biopharmaceutical company reported ($2.46) EPS for the quarter, beating analysts’ consensus estimates of ($2.50) by $0.04, Briefing.com reports. Sage Therapeutics had a negative return on equity of 37.03% and a negative net margin of 6,930.97%. The firm had revenue of $3.30 million […] ....

United Kingdom , Jeffreym Jonas , Steven Marc Paul , Therapeutics Inc , Alps Advisors Inc , Schonfeld Strategic Advisors , Morgan Stanley , Millennium Management , Needham Company , Sage Therapeutics Company Profile , Norges Bank , Sage Therapeutics , Get Rating , Director Jeffrey , Strategic Advisors , Alps Advisors , Douglas Covey , Sage Therapeutics Daily , Nasdaq Sage ,

Analysts Set Sage Therapeutics, Inc. (NASDAQ:SAGE) PT at $52.58

Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Rating) have been assigned an average rating of “Hold” from the fourteen research firms that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and four have assigned a buy […] ....

United Kingdom , Jeffreym Jonas , Steven Marc Paul , Needham Company , Metlife Investment Management , Exchange Traded Concepts , Mackenzie Financial Corp , Sage Therapeutics Inc , Great West Life Assurance Co , Therapeutics Inc , Sage Therapeutics Company Profile , Sage Therapeutics , Get Rating , Marketbeat Ratings , Director Jeffrey , Life Investment Management , West Life Assurance , Traded Concepts , Ivy Capital Management , Douglas Covey , Sage Therapeutics Daily , Nasdaq Sage ,

Sage Therapeutics (NASDAQ:SAGE) Stock Price Passes Below 50 Day Moving Average of $43.42

Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Rating) shares crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $43.42 and traded as low as $41.76. Sage Therapeutics shares last traded at $41.78, with a volume of 349,407 shares. Analyst Upgrades and Downgrades SAGE has been the […] ....

United Kingdom , Jeffreym Jonas , Steven Marc Paul , Advisor Group Holdings Inc , Jpmorgan Chase Co , First Trust Advisors , Vanguard Group Inc , Metlife Investment Management , Sage Therapeutics Inc , Therapeutics Inc , Sage Therapeutics Company Profile , Securities Exchange Commission , Needham Company , York Mellon Corp , Sage Therapeutics , Get Rating , Therapeutics Trading Down , Director Jeffrey , Exchange Commission , Group Holdings , New York Mellon Corp , Life Investment Management , Trust Advisors , Douglas Covey , Sage Therapeutics Daily , Nasdaq Sage ,